Medplus Health Services Ltd

Q4 FY26

Medplus Health Services Q4 FY26 earnings call: Revenue & Margins

Q: What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹690

Market cap₹8.3K Cr

P/E39.4

Updated23 Aug 2026

Read4 min read

The short version

MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone. The company expects to maintain or improve gross margins, driven by increasing private label share.

From Medplus Health Services Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

MedPlus aims to continue a balanced growth approach, focusing on both branded and private label products rather than aggressive private label expansion alone.
The company expects to add approximately 800 new stores in FY27, including both company-owned and franchisee stores, indicating continued network expansion.
Same-store sales growth (SSSG) target remains at an annualized rate of 9% to 10% over the next year.
Private label growth guidance remains intact, aiming for a 20-30 basis points increase every quarter in private label share.
Emphasis on increasing private label non-pharma product assortment to add topline and bottom-line benefits.

2 more points management made on revenue & sales performance

Profitability & Margins

The company expects to maintain or improve gross margins, driven by increasing private label share.
EBITDA margins are targeted to be stabilized around current levels (5.7%-5.8%) in the near term, with potential for gradual growth.
Same-store sales growth (SSSG) guidance is 9%-10% annualized, supporting steady revenue growth.
Expansion through franchisee model to accelerate store additions without diluting margins significantly.
Growth in private label non-pharma products is anticipated to contribute positively to both top-line and bottom-line.

2 more points management made on profitability & margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation. (Page 16)
Expansion through franchisee model is ongoing, with approximately 310 franchisee stores added recently, supporting faster network growth alongside company-owned store expansion. (Page 5)
The company expects to continue store additions (around 800 stores next year), split between owned and franchisee stores, with more detailed splits to be shared in the future. (Page 5)

- New warehouses may be added as the company expands into new states or further penetrates existing newer states like Madhya Pradesh and Chhattisgarh, though current warehouse capacity suffices for existing stores. (Page 7) - MedPlus is mindful about capital allocation focused on areas where it can add more value and achieve optimum shareholder returns, including private label manufacturing and supply chain enhancements. (Page 11) No specific quantitative capex guidance provided; focus remains on strategic store modernizations and network expansion.

2 more points management made on capital expenditure plans

Fundraising & Capital Structure

MedPlus Health Services Limited currently operates as a zero-debt company with no external loans on its books.
Interest expenses reported relate only to lease accounting, not actual loans.
The company has not indicated any plans for new fundraising through debt or equity in the near term.
Focus is on organic growth via store expansion (both company-owned and franchisee) and private label development.
Management prioritizes capital allocation to maximize returns, with no explicit announcements on fresh capital raises.

2 more points management made on fundraising & capital structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided document (pages 1-19 of MedPlus Health Services Limited May 21, 2026) does not contain any information related to current or expected order book or pending orders. The transcript mainly focuses on: - Inventory holding periods and returns (<1% returns) - Lease accounting and zero external debt - Warehouse inventory levels (30-33 days sustainable level) - Sales and margins including private label growth - Store formats and franchisee model details - Online vs physical store growth dynamics

2 more points management made on order book & pipeline

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.9K Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

Bhatia Communications & Retail (India) Ltd (Q4 FY26)
171.94 crores, up 65% YoY from Rs. Key concall takeaways from Bhatia Communications & Retail (India) Ltd's Q4 FY26 earnings call — and how it ranks against…
Just Dial Ltd (Q4 FY26)
Operating Revenue (4Q FY26):** ₹3,072 million, up 6.2% YoY from ₹2,892 million in 4Q FY25 (Page 55). Key concall takeaways from Just Dial Ltd's Q4 FY26…
TCC Concept Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹839.0 Mn, +160% YoY (Page 34) . Key concall takeaways from TCC Concept Ltd's Q4 FY26 earnings call — and how it ranks…
RattanIndia Enterprises Ltd (Q4 FY26)
Q4 FY26 Total Income: ₹1,647 Cr, up 13% from ₹1,464 Cr in Q4 FY25 (Page 5, 23) . Key concall takeaways from RattanIndia Enterprises Ltd's Q4 FY26 earnings call…

Compare:vs Eternal Ltd vs Avenue Super.vs Trent Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Medplus Health Services Ltd Q4 FY26 results?

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 39.4 with a market cap of ₹8,293 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medplus Health Services Ltd planning capital expenditure?

MedPlus plans to upgrade or modernize at least 600+ existing stores within the current year to accommodate more products, optimizing space and introducing smarter shelving/rack systems including pharma and non-pharma segmentation.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.